Ligand validation:6SMN

PLS: [3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-SERINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SMN_PLS_A_601	96%	19%	0.072	0.98	1.89	1.6	4	6	2	0	100%	1
6SMN_PLS_B_2402	94%	17%	0.075	0.974	1.89	1.69	3	4	2	0	100%	1
6SMN_PLS_C_601	93%	18%	0.082	0.979	1.89	1.65	3	6	1	0	100%	1
6SMW_PLS_B_601	96%	20%	0.07	0.981	1.83	1.59	2	5	2	0	100%	1
9J4G_PLS_A_501	98%	34%	0.056	0.975	1.24	1.37	2	3	1	0	100%	1
6AMH_PLS_C_401	95%	13%	0.076	0.98	2.6	1.43	3	4	1	0	100%	1
8H1Q_PLS_A_401	94%	33%	0.082	0.982	1.2	1.45	3	4	0	0	100%	1
2CLL_PLS_B_1395	93%	1%	0.079	0.974	4.42	3.22	13	14	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.